Compare SYK & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYK | SNPS |
|---|---|---|
| Founded | 1941 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0B | 79.0B |
| IPO Year | 1994 | 1994 |
| Metric | SYK | SNPS |
|---|---|---|
| Price | $348.29 | $420.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $417.50 | ★ $540.71 |
| AVG Volume (30 Days) | ★ 1.9M | 1.5M |
| Earning Date | 04-30-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 8.25 | N/A |
| EPS | ★ 8.40 | 0.34 |
| Revenue | ★ $25,116,000,000.00 | $5,081,542,000.00 |
| Revenue This Year | $9.85 | $39.19 |
| Revenue Next Year | $8.36 | $10.73 |
| P/E Ratio | ★ $41.34 | $1,227.88 |
| Revenue Growth | 11.16 | ★ 20.87 |
| 52 Week Low | $319.32 | $376.18 |
| 52 Week High | $404.87 | $651.65 |
| Indicator | SYK | SNPS |
|---|---|---|
| Relative Strength Index (RSI) | 54.18 | 52.90 |
| Support Level | $328.23 | $409.90 |
| Resistance Level | $375.26 | $447.88 |
| Average True Range (ATR) | 7.69 | 14.66 |
| MACD | 3.05 | 3.07 |
| Stochastic Oscillator | 80.79 | 78.91 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.